Related references
Note: Only part of the references are listed.A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Lisa I. Backus et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991-2006
S. A. McDonald et al.
EPIDEMIOLOGY AND INFECTION (2011)
Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: A systematic review
Stephen Corson et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2011)
A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Mark G. Swain et al.
GASTROENTEROLOGY (2010)
High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C
John P. Bate et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C
Fabio Tine et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study
E. K. Manesis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland
Scott A. McDonald et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users
J. Amin et al.
EPIDEMIOLOGY AND INFECTION (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
From trials to a real hospital setting:: Effectiveness of pegylated interferon-α-2b/ribavirin combination therapy for naive chronic hepatitis C patients
Guido Piai et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland
SJ Hutchinson et al.
HEPATOLOGY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Estimating progression to cirrhosis in chronic hepatitis C virus infection
AJ Freeman et al.
HEPATOLOGY (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Share Paper
